Stockreport

bluebird (BLUE) Tops on Q1 Sales, Zynteglo Progresses Well [Yahoo! Finance]

Hercules Capital, Inc.  (HTGC) 
Last hercules capital, inc. earnings: 2/20 04:10 pm Check Earnings Report
US:NYSE Investor Relations: investor.htgc.com
PDF The $16.2-million upside can be attributed to increased Zynteglo product revenues. The FDA approved Zynteglo for the treatment of beta-thalassemia in adult and pediat [Read more]